Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease
Conditions: Chagas Disease; LactationIntervention: Sponsors: Hospital de Niños R. Gutierrez de Buenos Aires; Hospital de Niños R. Gutierrez de Buenos AiresRecruiting - verified December 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2012 Category: Research Source Type: clinical trials
Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease
Conditions: Chagas Disease; LactationIntervention: Sponsor: Hospital de Niños R. Gutierrez de Buenos AiresCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2012 Category: Research Source Type: clinical trials
Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease
Conditions: Chagas Disease; LactationIntervention: Sponsors: Hospital de Niños R. Gutierrez de Buenos Aires; Hospital de Niños R. Gutierrez de Buenos AiresRecruiting - verified December 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2012 Category: Research Source Type: clinical trials
Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease
Conditions: Chagas Disease; LactationIntervention: Sponsor: Hospital de Niños R. Gutierrez de Buenos AiresCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2012 Category: Research Source Type: clinical trials
A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267)
Condition: Chagas DiseaseInterventions: Drug: Posaconazole; Drug: Placebo for posaconazole; Drug: BenznidazoleSponsor: Merck Sharp & Dohme Corp.Active, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2011 Category: Research Source Type: clinical trials
A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267)
Condition: Chagas DiseaseInterventions: Drug: Posaconazole; Drug: Placebo for posaconazole; Drug: BenznidazoleSponsor: Merck Sharp & Dohme Corp.Completed - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2011 Category: Research Source Type: clinical trials